Transgene-Free Cynomolgus Monkey iPSCs Generated under Chemically Defined Conditions

Non-human primates (NHPs) are pivotal animal models for translating novel cell replacement therapies into clinical applications, including validating the safety and efficacy of induced pluripotent stem cell (iPSC)-derived products. Preclinical development and the testing of cell-based therapies idea...

Full description

Bibliographic Details
Main Authors: Yuliia Tereshchenko, Nesil Esiyok, Enrique Garea-Rodríguez, Daniele Repetto, Rüdiger Behr, Ignacio Rodríguez-Polo
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/13/6/558
_version_ 1827306675834454016
author Yuliia Tereshchenko
Nesil Esiyok
Enrique Garea-Rodríguez
Daniele Repetto
Rüdiger Behr
Ignacio Rodríguez-Polo
author_facet Yuliia Tereshchenko
Nesil Esiyok
Enrique Garea-Rodríguez
Daniele Repetto
Rüdiger Behr
Ignacio Rodríguez-Polo
author_sort Yuliia Tereshchenko
collection DOAJ
description Non-human primates (NHPs) are pivotal animal models for translating novel cell replacement therapies into clinical applications, including validating the safety and efficacy of induced pluripotent stem cell (iPSC)-derived products. Preclinical development and the testing of cell-based therapies ideally comprise xenogeneic (human stem cells into NHPs) and allogenic (NHP stem cells into NHPs) transplantation studies. For the allogeneic approach, it is necessary to generate NHP-iPSCs with generally equivalent quality to the human counterparts that will be used later on in patients. Here, we report the generation and characterization of transgene- and feeder-free cynomolgus monkey (<i>Macaca fascicularis</i>) iPSCs (Cyno-iPSCs). These novel cell lines have been generated according to a previously developed protocol for the generation of rhesus macaque, baboon, and human iPSC lines. Beyond their generation, we demonstrate the potential of the novel Cyno-iPSCs to differentiate into two clinically relevant cell types, i.e., cardiomyocytes and neurons. Overall, we provide a resource of novel iPSCs from the most frequently used NHP species in the regulatory testing of biologics and classical pharmaceutics to expand our panel of iPSC lines from NHP species with high relevance in preclinical testing and translational research.
first_indexed 2024-04-24T18:26:38Z
format Article
id doaj.art-3a80dc75f3944dcb8776d95e08dd56b1
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-04-24T18:26:38Z
publishDate 2024-03-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-3a80dc75f3944dcb8776d95e08dd56b12024-03-27T13:30:45ZengMDPI AGCells2073-44092024-03-0113655810.3390/cells13060558Transgene-Free Cynomolgus Monkey iPSCs Generated under Chemically Defined ConditionsYuliia Tereshchenko0Nesil Esiyok1Enrique Garea-Rodríguez2Daniele Repetto3Rüdiger Behr4Ignacio Rodríguez-Polo5Research Platform Degenerative Diseases, German Primate Center-Leibniz Institute for Primate Research, Kellnerweg 4, 37077 Göttingen, GermanyResearch Platform Degenerative Diseases, German Primate Center-Leibniz Institute for Primate Research, Kellnerweg 4, 37077 Göttingen, GermanyCharles River Laboratories Germany GmbH, Hans-Adolf-Krebs-Weg 9, 37077 Göttingen, GermanyCharles River Laboratories Germany GmbH, Hans-Adolf-Krebs-Weg 9, 37077 Göttingen, GermanyResearch Platform Degenerative Diseases, German Primate Center-Leibniz Institute for Primate Research, Kellnerweg 4, 37077 Göttingen, GermanyResearch Platform Degenerative Diseases, German Primate Center-Leibniz Institute for Primate Research, Kellnerweg 4, 37077 Göttingen, GermanyNon-human primates (NHPs) are pivotal animal models for translating novel cell replacement therapies into clinical applications, including validating the safety and efficacy of induced pluripotent stem cell (iPSC)-derived products. Preclinical development and the testing of cell-based therapies ideally comprise xenogeneic (human stem cells into NHPs) and allogenic (NHP stem cells into NHPs) transplantation studies. For the allogeneic approach, it is necessary to generate NHP-iPSCs with generally equivalent quality to the human counterparts that will be used later on in patients. Here, we report the generation and characterization of transgene- and feeder-free cynomolgus monkey (<i>Macaca fascicularis</i>) iPSCs (Cyno-iPSCs). These novel cell lines have been generated according to a previously developed protocol for the generation of rhesus macaque, baboon, and human iPSC lines. Beyond their generation, we demonstrate the potential of the novel Cyno-iPSCs to differentiate into two clinically relevant cell types, i.e., cardiomyocytes and neurons. Overall, we provide a resource of novel iPSCs from the most frequently used NHP species in the regulatory testing of biologics and classical pharmaceutics to expand our panel of iPSC lines from NHP species with high relevance in preclinical testing and translational research.https://www.mdpi.com/2073-4409/13/6/558macaqueiPSCstem cellnon-human primateneuronal differentiationcardiac differentiation
spellingShingle Yuliia Tereshchenko
Nesil Esiyok
Enrique Garea-Rodríguez
Daniele Repetto
Rüdiger Behr
Ignacio Rodríguez-Polo
Transgene-Free Cynomolgus Monkey iPSCs Generated under Chemically Defined Conditions
Cells
macaque
iPSC
stem cell
non-human primate
neuronal differentiation
cardiac differentiation
title Transgene-Free Cynomolgus Monkey iPSCs Generated under Chemically Defined Conditions
title_full Transgene-Free Cynomolgus Monkey iPSCs Generated under Chemically Defined Conditions
title_fullStr Transgene-Free Cynomolgus Monkey iPSCs Generated under Chemically Defined Conditions
title_full_unstemmed Transgene-Free Cynomolgus Monkey iPSCs Generated under Chemically Defined Conditions
title_short Transgene-Free Cynomolgus Monkey iPSCs Generated under Chemically Defined Conditions
title_sort transgene free cynomolgus monkey ipscs generated under chemically defined conditions
topic macaque
iPSC
stem cell
non-human primate
neuronal differentiation
cardiac differentiation
url https://www.mdpi.com/2073-4409/13/6/558
work_keys_str_mv AT yuliiatereshchenko transgenefreecynomolgusmonkeyipscsgeneratedunderchemicallydefinedconditions
AT nesilesiyok transgenefreecynomolgusmonkeyipscsgeneratedunderchemicallydefinedconditions
AT enriquegarearodriguez transgenefreecynomolgusmonkeyipscsgeneratedunderchemicallydefinedconditions
AT danielerepetto transgenefreecynomolgusmonkeyipscsgeneratedunderchemicallydefinedconditions
AT rudigerbehr transgenefreecynomolgusmonkeyipscsgeneratedunderchemicallydefinedconditions
AT ignaciorodriguezpolo transgenefreecynomolgusmonkeyipscsgeneratedunderchemicallydefinedconditions